Carregant...
Decreased CSF Aβ42 correlates with brain atrophy in cognitively normal elderly
OBJECTIVES: In order for therapies for Alzheimer's disease (AD) to have the greatest impact, it will likely be necessary to treat individuals in the “preclinical” (presymptomatic) stage. Fluid and neuroimaging measures are being explored as possible biomarkers of AD pathology that could aid in...
Guardat en:
| Autors principals: | , , , , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2009
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2763631/ https://ncbi.nlm.nih.gov/pubmed/19260027 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ana.21559 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|